| |
AIDS cases
|
Early mortality
| |
|---|
| |
No.
|
No. (%)
|
OR (95 % CI)
|
|---|
|
AIDS-defining diseasesb
|
|
Infectious diseases
|
|
Pneumocystis carinii pneumonia
|
2650
|
393 (14.8)
|
1c
|
|
Tuberculosis
|
1089
|
126 (11.6)
|
0.81 (0.65-1.00)
|
|
Candidiasis
|
2943
|
404 (13.7)
|
0.84 (0.72-0.98)
|
|
Recurrent pneumonia
|
466
|
62 (13.3)
|
0.91 (0.68-1.23)
|
|
Other infections
|
1476
|
266 (18.0)
|
1.22 (1.02-1.45)
|
|
Brain toxoplasmosis
|
856
|
175 (20.4)
|
1.43 (1.16-1.75)
|
|
Neoplasms
|
|
Invasive cervical cancer
|
104
|
9 (8.7)
|
0.59 (0.29-1.24)
|
|
Kaposi sarcoma
|
773
|
80 (10.4)
|
0.82 (0.63-1.07)
|
|
Immunoblastic lymphoma
|
707
|
234 (33.1)
|
3.18 (2.59-3.89)
|
|
Burkitt lymphoma
|
286
|
95 (33.2)
|
3.48 (2.62-4.62)
|
|
Primary brain lymphoma
|
85
|
54 (63.5)
|
11.66 (7.32-18.57)
|
|
Other conditions
|
|
HIV encephalopathy
|
999
|
231 (23.1)
|
1.55 (1.28-1.88)
|
|
HIV wasting syndrome
|
1655
|
436 (26.3)
|
1.78 (1.52-2.09)
|
|
Progressive multifocal leukoencephalopathy
|
463
|
192 (41.5)
|
4.21 (3.37-5.27)
|
|
No. of AIDS-defining diseases at diagnosis
|
|
1
|
11670
|
2048 (17.6)
|
1c
|
|
2
|
2261
|
510 (22.6)
|
1.27 (1.13-1.42)
|
|
≥3
|
621
|
199 (32.1)
|
1.97 (1.64-2.37)
|
- aOdds ratios (OR) and 95 % confidence intervals (CI) estimated using multivariate logistic regression models adjusted for age, gender, area of residence, education, HIV transmission mode, year and CD4 cell count at AIDS diagnosis
- bFor patients with more than one AIDS-defining disease, only the most severe was considered
- cReference category
